S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
Critical asset just had biggest fall on record (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
Critical asset just had biggest fall on record (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
Critical asset just had biggest fall on record (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
Critical asset just had biggest fall on record (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations

Agile Therapeutics (AGRX) Earnings Date, Estimates & Call Transcripts

$0.85
+0.05 (+6.25%)
(As of 03/1/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

AGRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AGRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AGRX Earnings Date and Information

Agile Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off prior year's report dates.

Agile Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/27/2024
Estimated)
------- 
11/9/2023Q3 2023-($1.47)($1.47)($2.67)-$6.66 million
8/9/2023Q2 2023($3.48)($3.10)+$0.38($4.05)$4.68 million$5.50 million
5/11/2023Q1 2023-($7.76)($7.76)($9.61)-$3.81 million
3/22/2023Q4 2022($10.50)($9.00)+$1.50($13.00)$3.17 million$4.00 million
11/7/2022Q3 2022($0.30)($0.23)+$0.07$0.07$2.46 million$3.00 million
8/11/2022Q2 2022-($2.71)($2.71)($2.71)$2.13 million$2.13 million    
5/12/2022Q1 2022-($3.78)($3.78)($3.78)-$1.76 million
3/30/2022Q4 2021($6.80)($8.00)($1.20)($0.20)$1.58 million$1.51 million    
11/2/2021Q3 2021($7.60)($7.20)+$0.40($0.18)$1.49 million$1.29 million    
7/25/2021Q2 2021($8.80)($8.00)+$0.80($0.20)$1.45 million$1.19 million    
5/3/2021Q1 2021($8.40)($8.00)+$0.40($0.20)$0.65 million$0.12 million  












Agile Therapeutics Earnings - Frequently Asked Questions

When is Agile Therapeutics's earnings date?

Agile Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 27th, 2024 based off last year's report dates. Learn more on AGRX's earnings history.

How much revenue does Agile Therapeutics generate each year?

Agile Therapeutics (NASDAQ:AGRX) has a recorded annual revenue of $10.88 million.

How much profit does Agile Therapeutics generate each year?

Agile Therapeutics (NASDAQ:AGRX) has a recorded net income of -$25.41 million. AGRX has generated -$13.33 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:AGRX) was last updated on 3/2/2024 by MarketBeat.com Staff